Alessandro Colasanti

4.4k total citations · 1 hit paper
67 papers, 3.0k citations indexed

About

Alessandro Colasanti is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Alessandro Colasanti has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in Alessandro Colasanti's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Schizophrenia research and treatment (12 papers) and Bipolar Disorder and Treatment (11 papers). Alessandro Colasanti is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Schizophrenia research and treatment (12 papers) and Bipolar Disorder and Treatment (11 papers). Alessandro Colasanti collaborates with scholars based in United Kingdom, Italy and United States. Alessandro Colasanti's co-authors include David Nutt, Eugenii A. Rabiner, David Erritzøe, Roger N. Gunn, Paul M. Matthews, Laurence Reed, Massimo Carlo Mauri, Robert Leech, Kevin Murphy and Robin Carhart‐Harris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alessandro Colasanti

63 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

2012 737 citations David Erritzøe, Alessandro Colasanti et al. profile →

Peers

Countries citing papers authored by Alessandro Colasanti

Since Specialization

Citations

This map shows the geographic impact of Alessandro Colasanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Colasanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Colasanti more than expected).

Fields of papers citing papers by Alessandro Colasanti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Colasanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Colasanti. The network helps show where Alessandro Colasanti may publish in the future.

Co-authorship network of co-authors of Alessandro Colasanti

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Colasanti. A scholar is included among the top collaborators of Alessandro Colasanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Colasanti. Alessandro Colasanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered oxidative neurometabolic response to methylene blue in bipolar disorder revealed by quantitative neuroimaging 2024 ·Journal of Affective Disorders ·(unknown), (unknown), Nefize Yalın, Ivor Simpson, (unknown), (unknown), Riccardo De Marco, (unknown), (unknown), Nisha Singh, Nicholas P. Blockley, Alan J. Stone, Federico Turkheimer, Allan H. Young, Mara Cercignani, Fernando Zelaya, Iris Asllani, Alessandro Colasanti	2
2	Effects of brief remote high ventilation breathwork with retention on mental health and wellbeing: a randomised placebo-controlled trial 2024 ·Scientific Reports ·(unknown), Elissa Epel, Alessandro Colasanti, Clara Strauss, Kate Cavanagh	0
3	A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia 2023 ·Heliyon ·Sarah Partridge, Lisa Quadt, (unknown), Jessica Eccles, Charlotte Thompson, Alessandro Colasanti, Stephen Bremner, Christopher I. Jones, Karin Due Bruun, Harm van Marwijk	6
4	The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats 2023 ·Journal of Cerebral Blood Flow & Metabolism ·Nisha Singh, Eilidh MacNicol, Ottavia Dipasquale, Karen Randall, David J. Lythgoe, Ndaba Mazibuko, Camilla Simmons, Pierluigi Selvaggi, (unknown), Federico Turkheimer, Diana Cash, Fernando Zelaya, Alessandro Colasanti	5
5	In vivo quantitative imaging of hippocampal inflammation in autoimmune neuroinflammatory conditions: a systematic review 2022 ·Clinical & Experimental Immunology ·(unknown), Mara Cercignani, Alessandro Colasanti	5
6	Acute acetate administration increases endogenous opioid levels in the human brain: A [¹¹C]carfentanil molecular imaging study 2021 ·Journal of Psychopharmacology ·Abhishekh H. Ashok, Jim Myers, Gary Frost, Samuel Turton, Roger N. Gunn, Jan Passchier, Alessandro Colasanti, Tiago Reis Marques, David Nutt, Anne Lingford‐Hughes, Oliver Howes, Eugenii A. Rabiner	2
7	Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge 2019 ·Neuropsychopharmacology ·David Erritzøe, Abhishekh H. Ashok, Graham E. Searle, Alessandro Colasanti, Samuel Turton, Yvonne Lewis, Mickaël Huiban, (unknown), Jan Passchier, Azeem Saleem, John D. Beaver, Anne Lingford‐Hughes, David Nutt, Oliver Howes, Roger N. Gunn, Gitte M. Knudsen, Eugenii A. Rabiner	33
8	Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up 2017 ·Asian Journal of Psychiatry ·Massimo Carlo Mauri, Chiara Di Pace, (unknown), Silvia Paletta, Alessandro Colasanti	26
9	¹¹C-PBR28 and ¹⁸F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis 2017 ·Journal of Nuclear Medicine ·Gourab Datta, Alessandro Colasanti, Nicola J. Kalk, David R. Owen, Gregory Scott, Eugenii A. Rabiner, Roger N. Gunn, Anne Lingford‐Hughes, Omar Malik, Olga Ciccarelli, Richard Nicholas, (unknown), Marco Battaglini, Nicola De Stefano, Paul M. Matthews	63
10	Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions 2016 ·NeuroImage Clinical ·Courtney Bishop, Rexford D. Newbould, (unknown), Lesley Honeyfield, Rebecca Quest, Alessandro Colasanti, Rehiana Ali, Miriam Mattoscio, Antonio Cortese, Richard Nicholas, Paul M. Matthews, Paolo A. Muraro, Adam Waldman	23
11	Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis 2015 ·Biological Psychiatry ·Alessandro Colasanti, Qi Guo, Paolo Giannetti, Matthew B. Wall, Rexford D. Newbould, Courtney Bishop, Mayca Onega, Richard Nicholas, Olga Ciccarelli, Paolo A. Muraro, Omar Malik, David R. Owen, Allan H. Young, Roger N. Gunn, Paola Piccini, Paul M. Matthews, Eugenii A. Rabiner	110
12	In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism 2014 ·Neuropsychopharmacology ·David Erritzøe, Andri C. Tziortzi, David Bargiela, Alessandro Colasanti, Graham E. Searle, Roger N. Gunn, John D. Beaver, Adam Waldman, David Nutt, Massimo Bani, Emilio Merlo‐Pich, Eugenii A. Rabiner, Anne Lingford‐Hughes	49
13	Quantification of the Specific Translocator Protein Signal of ¹⁸F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding 2013 ·Journal of Nuclear Medicine ·Qi Guo, Alessandro Colasanti, David R. Owen, Mayca Onega, (unknown), Idriss Bennacef, Paul M. Matthews, Eugenii A. Rabiner, Federico Turkheimer, Roger N. Gunn	79
14	Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO) 2013 ·Psychoneuroendocrinology ·Alessandro Colasanti, David R. Owen, Detelina Grozeva, Eugenii A. Rabiner, Paul M. Matthews, Nick Craddock, Allan H. Young	43
15	On the Psychotropic Effects of Carbon Dioxide 2012 ·Current Pharmaceutical Design ·Alessandro Colasanti, Gabriel Esquivel, (unknown), Eric Griez	21
16	Depressive dimension, clinical outcome, and duration of hospitalization in acute schizophrenia 2010 ·Asian Journal of Psychiatry ·Massimo Carlo Mauri, Silvia Paletta, (unknown), Alessandro Colasanti, Carlo Altamura	3
17	Psychiatric diagnosis and aggression before acute hospitalisation 2007 ·European Psychiatry ·Alessandro Colasanti, (unknown), (unknown), (unknown), (unknown), Maddalena Mauri	26
18	Clinical Pharmacokinetics of Atypical Antipsychotics 2007 ·Clinical Pharmacokinetics ·Massimo Carlo Mauri, L.S. Volonteri, Alessandro Colasanti, A. Fiorentini, (unknown), S.R. Bareggi	197
19	A Single-blind, Randomized Comparison of Olanzapine at a Starting Dose of 5 mg Versus 20 mg in Acute Schizophrenia 2006 ·Clinical Neuropharmacology ·Massimo Carlo Mauri, Alessandro Colasanti, (unknown), (unknown), (unknown), (unknown)	7
20	Acute, continuation and maintenance phases of antidepressant treatment 2005 ·Massimo Carlo Mauri, L.S. Volonteri, Alessandro Colasanti, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact